Seven-Year Case-Control Study in California of Risk Factors for Infant Botulism

Mayuri V Panditrao1, Haydee A Dabritz1, N Neely Kazerouni1

  • 1Infant Botulism Treatment and Prevention Program, California Department of Public Health, Richmond, CA.

Insights

Infant botulism risk factors in California included slower intestinal transit time (≤1 bowel movement/day) in infants under two months old. Other identified factors varied by control group and infant age, with few consistent associations found.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Infant botulism is an intestinal infectious form of human botulism.
  • The condition was first recognized in California in 1976.

Purpose of the Study:

  • To identify potential risk factors for infant botulism.
  • Investigate factors in the years following its initial recognition.

Main Methods:

  • Case-control study involving 159 infant botulism cases and 318 healthy controls.
  • Comprehensive questionnaires (>300 factors) and age-stratified logistic regression analyses were used.
  • Two control groups were utilized: neighborhood controls and county controls.

Main Results:

  • Slower intestinal transit time (≤1 bowel movement/day) was associated with infant botulism, except in the ≤2-month-old county controls group.
  • Risk factors differed based on infant age and the type of control group used.
  • Factors like birth order >1, cesarean delivery, and windy residence area were associated with illness in some analyses.

Conclusions:

  • Slower intestinal transit time is a significant risk factor for infant botulism.
  • Few consistent physiologic, environmental, or maternal factors were identified across all analyses.
  • The study highlights the complexity of identifying risk factors for infant botulism.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
155